StockWatch
·
Pharmaceuticals
Clarification10 Sept 2026, 05:30 pm

Eris Lifesciences Clarifies Loan Value Amidst Rumors

AI Summary

Eris Lifesciences Limited has issued a clarification regarding recent publications from InvestyWise News, dealroom.co, and others that may have misrepresented the company's loan value. The company directs readers to refer to its official disclosures disseminated through the exchange for accurate information. This statement serves to verify and correct any potential misinformation concerning the company's financial dealings, emphasizing reliance on official exchange filings for investment decisions.

Key Highlights

  • Eris Lifesciences clarifies rumor verification as per Regulation 30 (11).
  • Company directs reliance on official exchange disseminated information.
  • Correct loan value is as per previous company disclosures.
  • Readers advised to refer to official filings for investment decisions.